SEC v. Brian J. Suthoff

Brian Suthoff allegedly avoided losses of almost $20,000 by trading ahead of negative news announced by Cambridge, Massachusetts-based biopharmaceutical company Sage Therapeutics, Inc. According to the SEC's complaint, Suthoff misappropriated non-public information regarding the FDA's position on Sage's application for approval of its drug for the treatment of major depressive disorder (MDD).

Summary generated from official Securities and Exchange Commission press release